Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma

Author:

Vaios Eugene J.1,Batich Kristen A.2,Buckley Anne F.3,Dunn-Pirio Anastasie4,Patel Mallika P.5,Kirkpatrick John P.1,Goudar Ranjit6,Peters Katherine B.7

Affiliation:

1. Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA

2. Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA

3. Department of Pathology, Duke University Medical Center, Durham, NC, USA

4. Department of Neurology, UC San Diego Health, San Diego, CA, USA

5. Department of Pharmacy, Duke University Medical Center, Durham, NC, USA

6. Virginia Oncology Associates, Norfolk, VA, USA

7. Departments of Neurosurgery and Neurology, Duke University Medical Center, Durham, NC, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference30 articles.

1. Diagnosis and treatment of primary CNS lymphoma;Schlegel;Nat Rev Neurol,2013

2. Low-dose whole brain radiotherapy combined with radiosurgery for primary CNS lymphoma achieving partial response to induction methotrexate-based chemotherapy;Kirkpatrick;J Radiosurg SBRT,2014

3. Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology;Dietrich;Neuro Oncol,2019

4. Corticosteroids in brain cancer patients: benefits and pitfalls;Kesari;Expert Rev Clin Pharmacol,2011

5. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system;Jackson;Int J Radiat Oncol Biol Phys,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3